CMS-10823 ESRD QIP M&E Supporting Statement Part B 12-20-22

CMS-10823 ESRD QIP M&E Supporting Statement Part B 12-20-22.docx

End-stage Renal Disease (ESRD) Quality Incentive Program (QIP): Study of Quality and Patient Experience (CMS-10823)

OMB: 0938-1450